Neointimal Hyperplasia

Acronym

Definition

NIH

National Institutes of Health (US)

NIH

News in Health (National Institutes of Health)

NIH

Not Invented Here

NIH

Neointimal Hyperplasia

NIH

National Institute of Hydrology (India)

NIH

Natural Infant Hygiene

References in periodicals archive	?		Acronyms browser	?		Full browser	?
quot; The PAINT TRIAL nine months angiographic results analyzed by Cardialysis (Rotterdam, Netherlands) showed that the head-to-head comparison between two novel DES (Paclitaxel & Sirolimus), both the novel DES were effective in reducing neointimal hyperplasia, late lumen loss, 1-year re-intervention and adverse cardiac event during first year compared to Bare metal stent. Catheterization and Cardiovascular Interventions (CCI) Journal ... by J P Dutta / Food/cooking/nutrition community Sustained expression of MCP-1 may be more important than VCAM-1 in the process of neointimal hyperplasia featured by predominant SMC in the CAL mouse model since MCP-1 may both trigger the initial influx of leukocytes into the vessel wall and help to perpetuate the development of the intimal lesion by stimulating the proliferation and migration of SMC in intima. Endothelial nitric oxide synthase deficiency enhanced carotid artery ... by Zhang, Le-ning; da Cunha, Valdeci; Martin-McNulty, Baby; Wilson, Dennis; Sullivan, Mark E.; Vergona, / Journal of Applied Research About Estradiol Suppression of neointimal hyperplasia, the underlying cause of in-stent restenosis, by 17 beta-estradiol released from the stent surface, represents a novel approach for drug eluting stents and is the basis for the ETHOS I clinical study. X-CELL MEDICAL COMPLETES ENROLLMENT FOR ETHOS I TRIAL by Biotech Equipment Update	NEOBA NEOBIG NEOC NEOCam NEOCH NEOCN NEOCO NEOCP NEOCS NEODA NEODAAS NEODF NEODGA NEODTC NEODTD NEODYS NEOEA NEOESR NEOEX NEOF NEOFB NEOFF NEOG NEOHS NEOIC Neointimal Hyperplasia NEOMAP NEOME NEOMIN NEOMM NEON Neon64 NEONET NEONPG NEONS NEOOC NEOP NEOPA NEOPS NEORSD NEOS NEOSA NEOSH NEOST NEOT NEOTA NEOTAM NEOTEC NEOUCOM NEOWA NEP	Neoglucogenesis Neognath Neognathae Neognathe Neognathism Neognostic Neognostic Neogomesia Neogomezia Neogothic Neogrammarian Neogrammarian Neogrammarian hypothesis Neogrammarian hypothesis Neogrammarians Neogrammarians Neography Neogregarinida NeoHacks Neohemocyte Neohexane neohexane alkylation NEOHS Neohygrophorus Neohygrophorus angelesianus NEOIC neoimpressionism neoimpressionism neoimpressionist neoimpressionist Neointimal Hyperplasia Neointimal Hyperplasia Area Neointuitionism Neointuitionism Neoist International Neokantian Neokantian Neokantianism Neokantianism Neokantianismus Neokantianismus neokinetic neolalia Neolatin Neolatin Neolatine language neolatry Neolehmannia Neolentinus Neolentinus ponderosus neoliberal Neoliberal economics neoliberalism Neoliberalism economics Neoliberalism/Archive 1 Neoliberals Neoligism Neoligism Neoligism Neoligism Neolin

References in periodicals archive

Acronyms browser

Full browser

quot; The PAINT TRIAL nine months angiographic results analyzed by Cardialysis (Rotterdam, Netherlands) showed that the head-to-head comparison between two novel DES (Paclitaxel & Sirolimus), both the novel DES were effective in reducing neointimal hyperplasia, late lumen loss, 1-year re-intervention and adverse cardiac event during first year compared to Bare metal stent.

Catheterization and Cardiovascular Interventions (CCI) Journal ... by J P Dutta / Food/cooking/nutrition community

Sustained expression of MCP-1 may be more important than VCAM-1 in the process of neointimal hyperplasia featured by predominant SMC in the CAL mouse model since MCP-1 may both trigger the initial influx of leukocytes into the vessel wall and help to perpetuate the development of the intimal lesion by stimulating the proliferation and migration of SMC in intima.

Endothelial nitric oxide synthase deficiency enhanced carotid artery ... by Zhang, Le-ning; da Cunha, Valdeci; Martin-McNulty, Baby; Wilson, Dennis; Sullivan, Mark E.; Vergona, / Journal of Applied Research

About Estradiol Suppression of neointimal hyperplasia, the underlying cause of in-stent restenosis, by 17 beta-estradiol released from the stent surface, represents a novel approach for drug eluting stents and is the basis for the ETHOS I clinical study.

X-CELL MEDICAL COMPLETES ENROLLMENT FOR ETHOS I TRIAL by Biotech Equipment Update